MedTrace Logo

Phenytoin in Treatment of Atrophic Post Acne Scars.

NCT06942468 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-04-24

No results posted yet for this study

Summary

To evaluate the efficacy and safety of topical phenytoin spanlastics as an adjuvant therapy in treatment of atrophic post acne scars.

To compare the efficacy of topical phenytoin spanlastics combined with fractional co2 laser versus fractional co2 laser alone in treatment of atrophic post acne scars.

Conditions

  • Atrophic Acne Scar

Interventions

DRUG

Topical nano preparation of Phenytoin

Topical nano preparation of Phenytoin will be used to treat atrophic post-acne scars. It will be in form of spanlastics.

DEVICE

Fractional CO2 laser

Fractional CO2 laser will be used alone for treatment of atrophic post acne scars.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-07-01
Completion
2027-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06942468 on ClinicalTrials.gov